Logo image
Scleromyxedema and inflammatory myopathy: A  clinicopathology study of three patients
Journal article   Peer reviewed

Scleromyxedema and inflammatory myopathy: A clinicopathology study of three patients

J.M. Harvey, P.J. Zilko, P.S. Cheah, F.L. Mastaglia and V.J. Ojeda
Australian and New Zealand Journal of Medicine, Vol.16(3), pp.329-335
1986
url
Link to Published Version *Subscription may be requiredView

Abstract

Scleromyxedema (lichen myxedematosus is a rare cutaneous manifestation in patients with idiopathic inflammatory myopathy. The clinical and histological findings in three patients with this association are presented. Two patients had a severe inflammatory polymyopathy which responded incompletely to corticosteroid therapy, while in the third, who developed esophageal carcinoma, the myopathy was relatively mild and the skin changes were the dominant feature. The occurrence of scleromyxedema in patients with inflammatory myopathy appears to carry a poor prognosis.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.213 Thyroid Disorders
1.213.1999 Graves' Ophthalmopathy
Web Of Science research areas
Medicine, General & Internal
ESI research areas
Clinical Medicine
Logo image